Skip to main content
CDC Website

STI

Cephalosporin Susceptibility Among Neisseria gonorrhoeae Isolates --- United States, 2000--2010

This report summarizes trends in cephalosporin susceptibility among N. gonorrhoeae isolates in the United States during 2000--2010 using data from the Gonococcal Isolate Surveillance Project (GISP). During that period, the percentage of isolates with elevated minimum inhibitory concentrations (MICs) to cephalosporins (=0.25 µg/mL for cefixime and =0.125 µg/mL for ceftriaxone) increased from 0.2% in 2000 to 1.4% in 2010 for cefixime and from 0.1% in 2000 to 0.3% in 2010 for ceftriaxone.

Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011

On October 25, 2011, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of quadrivalent human papillomavirus (HPV) vaccine (HPV4; Gardasil, Merck & Co. Inc.) in males aged 11 or 12 years. ACIP also recommended vaccination with HPV4 for males aged 13 through 21 years who have not been vaccinated previously or who have not completed the 3-dose series; males aged 22 through 26 years may be vaccinated. These recommendations replace the October 2009 ACIP guidance that HPV4 may be given to males aged 9 through 26 years.

Legal/Policy Toolkit for Adoption and Implementation of Expedited Partner Therapy

This Toolkit is the principal outcome of the second phase of the EPT law project. It is intended as a resource for voluntary use by government officials at the state and local levels, their public and private sector partners, and others who are interested in adopting or facilitating the implementation of statutes or regulations that permit EPT in clinical practice. This Toolkit is not designed to provide specific legal guidance or advice and does not represent the official legal positions of federal, state, or local governments.

[Genital Warts]

This pamphlet provides the general public with information on genital warts. The pamphlet discusses various types of warts, transmission, symptoms, medical treatment, and the relationship of warts to cancer. Contact information is provided for sexual health services in Australia.

Genital Warts

This pamphlet provides the general public with information on genital warts. The pamphlet discusses various types of warts, transmission, symptoms, medical treatment, and the relationship of warts to cancer. Contact information is provided for sexual health services in Australia.

Sexually Transmitted Infections among Young Americans

This infographic, in the form of an information sheet, highlights the impact, causes, and consequences of STDs among young people – and what they can do to protect themselves. While STDs affect individuals of all ages, STDs take a particularly heavy toll on young people. CDC estimates that youth ages 15-24 make up just more than 25 percent of the sexually active population, but account for half of the 20 million new STIs that occur in the United States each year. The infographic provides statistics on gonorrhea, chlamydia, HPV, genital herpes, HIV, and syphilis.

Incidence, Prevalence, and Cost of Sexually Transmitted Infections in the United States

This fact sheet explains two analyses published by CDC that examined the severe human and economic burden of sexually transmitted infections (STIs) in the United States. The new estimates indicate that there are about 20 million new U.S. infections each year, half of which occur among the nation’s youth. Also, there are more than 110 million STIs in the United States, which cost the health care system approximately $16 billion in medical costs alone.
Was this page helpful? Give Feedback